What can rheumatologists learn from translational cancer therapy?

Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management

(2012) Animesh Pardanani   AMERICAN JOURNAL OF HEMATOLOGY

Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management

(2012) Elias Jabbour et al.   AMERICAN JOURNAL OF HEMATOLOGY

Inflammation and ovarian cancer

(2012) Antonio Macciò et al.   CYTOKINE

The role of tocilizumab in the management of rheumatoid arthritis

(2012) Zoe Ash et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Inflammation-Associated Cancer Development in Digestive Organs: Mechanisms and Roles for Genetic and Epigenetic Modulation

(2012) Tsutomu Chiba et al.   GASTROENTEROLOGY

DNA damage by reactive species: Mechanisms, mutation and repair

(2012) N R Jena   JOURNAL OF BIOSCIENCES

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

(2012) Jonathan P Sherlock et al.   NATURE MEDICINE

Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment

(2012) Patricia Mucci LoRusso   ONCOLOGY

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

(2012) L. K. Mercer et al.   RHEUMATOLOGY

CD248 facilitates tumor growth via its cytoplasmic domain

(2011) Margarida Maia et al.   BMC CANCER

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

(2010) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

CD248 and its cytoplasmic domain: A therapeutic target for arthritis

(2010) Margarida Maia et al.   ARTHRITIS AND RHEUMATISM

NF-κB and STAT3 – key players in liver inflammation and cancer

(2010) Guobin He et al.   CELL RESEARCH

Imatinib mesylate induces clinical remission in rheumatoid arthritis

(2010) Ivânio Pereira et al.   JOINT BONE SPINE

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein- 

(2010) M. Kraman et al.   SCIENCE

Secondary tumours in Sjögren's syndrome

(2009) László Kovács et al.   AUTOIMMUNITY REVIEWS

Environmental factors promoting bladder cancer

(2009) Yoshihiko Hirao et al.   CURRENT OPINION IN UROLOGY

Anakinra for Rheumatoid Arthritis: A Systematic Review

(2009) M. MERTENS et al.   JOURNAL OF RHEUMATOLOGY

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

(2008) E. R. Brown et al.   ANNALS OF ONCOLOGY

Cytokines: From Gut Inflammation to Colorectal Cancer

(2008) Massimo Fantini et al.   CURRENT DRUG TARGETS

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells

(2008) Ilaria Marigo et al.   IMMUNOLOGICAL REVIEWS